Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 3226 AL 3240

Transgenic animal models of neurodegeneration based on human genetic studies

Harvey BK, Richie CT, Hoffer BJ, Airavaara M.

J Neural Transm (Vienna). 2011 Jan;118(1):27-45. doi: 10.1007/s00702-010-0476-6. Epub 2010 Oct 8.

Early atrophy of pallidum and accumbens nucleus in Huntington's disease

van den Bogaard SJ, Dumas EM, Acharya TP, Johnson H, Langbehn DR, Scahill RI, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA; TRACK-HD Investigator Group.

J Neurol. 2011 Mar;258(3):412-20. doi: 10.1007/s00415-010-5768-0. Epub 2010 Oct 9.

Long-term follow-up of pallidal deep brain stimulation in two cases of Huntington's disease

Kang GA, Heath S, Rothlind J, Starr PA.

J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):272-7. doi: 10.1136/jnnp.2009.202903. Epub 2010 Oct 25.

Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum)

Subramaniam S, Snyder SH.

Neuropharmacology. 2011 Jun;60(7-8):1187-92. doi: 10.1016/j.neuropharm.2010.10.025. Epub 2010 Oct 31.

Huntington's disease: From molecular basis to therapeutic advances

Krobitsch S, Kazantsev AG.

Int J Biochem Cell Biol. 2011 Jan;43(1):20-4. doi: 10.1016/j.biocel.2010.10.014. Epub 2010 Nov 4.

A systematic review of the incidence and prevalence of long-term neurological conditions in the UK

Hoppitt T, Pall H, Calvert M, Gill P, Yao G, Ramsay J, James G, Conduit J, Sackley C.

Neuroepidemiology. 2011;36(1):19-28. doi: 10.1159/000321712. Epub 2010 Nov 17.

Acute postinfectious movement and psychiatric disorders in children and adolescents

Mink J, Kurlan R.

J Child Neurol. 2011 Feb;26(2):214-7. doi: 10.1177/0883073810378534. Epub 2010 Nov 22.

Treatment of paroxysmal dyskinesias

Strzelczyk A, Bürk K, Oertel WH.

Expert Opin Pharmacother. 2011 Jan;12(1):63-72. doi: 10.1517/14656566.2010.513971. Epub 2010 Nov 26.

Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases

Gibrat C, Cicchetti F.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):380-9. doi: 10.1016/j.pnpbp.2010.11.023. Epub 2010 Nov 24.

Mechanisms mediating brain and cognitive reserve: experience-dependent neuroprotection and functional compensation in animal models of neurodegenerative diseases

Nithianantharajah J, Hannan AJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):331-9. doi: 10.1016/j.pnpbp.2010.10.026. Epub 2010 Nov 26.

Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases

Reddy PH, Reddy TP, Manczak M, Calkins MJ, Shirendeb U, Mao P.

Brain Res Rev. 2011 Jun 24;67(1-2):103-18. doi: 10.1016/j.brainresrev.2010.11.004. Epub 2010 Dec 8.

Comprehensive analysis of the genes responsible for neuroacanthocytosis in mood disorder and schizophrenia

Shimo H, Nakamura M, Tomiyasu A, Ichiba M, Ueno S, Sano A.

Neurosci Res. 2011 Mar;69(3):196-202. doi: 10.1016/j.neures.2010.12.001. Epub 2010 Dec 9.

Huntington's disease and Group I metabotropic glutamate receptors

Ribeiro FM, Pires RG, Ferguson SS.

Mol Neurobiol. 2011 Feb;43(1):1-11. doi: 10.1007/s12035-010-8153-1. Epub 2010 Dec 9.

Hemichorea-hemiballismus in non-ketotic hyperglycaemia

Cheema H, Federman D, Kam A.

J Clin Neurosci. 2011 Feb;18(2):293-4. doi: 10.1016/j.jocn.2010.04.036. Epub 2010 Dec 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias